Work

Abstract 2896: Transforming treatment paradigms: A cutting-edge polθ Inhibitor (DWP223) targeting PARP resistance in BRCA-mutant cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2896

Authors: Juno Kim, Jie Luo, Bin Cao, Ling Zhao, Xiaojing Zhang, Xiaohua Lin, Xiaojing Lin

Institutions: Daewoong Pharmaceutical (South Korea), XtalPi (China)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689587

Cites:

Cited by:

Related to: 10